Valuation Laboratorio Farmaceutico Erfo S.p.A.

Stocks

Market Closed - Borsa Italiana Other stock markets 01:45:00 13/06/26 am AEST			5-day change	1st Jan Change
1.100 ^EUR	+0.92%		0.00%	-25.17%

04/06	Equities trend higher; banks lead gains on the MIB	AN
22/05	European markets rebound; STM and Stellantis lead gains	AN

Data adjusted to current consolidation scope

Fiscal Period: December	2022	2023	2024	2025
Market Cap ¹	18.27	11.79	10.8	12.53
Change	-	-35.47%	-8.4%	16.03%
Enterprise Value (EV) ¹	17.38	11.41	10.81	12.83
Change	-	-34.34%	-5.31%	18.7%
P/E Ratio	25.5x	19.1x	30.8x	17x
PBR	2.33x	1.43x	1.44x	1.57x
PEG	-0.3x	-1.4x	-0.8x	0x
Capitalization / Revenue	3.87x	1.99x	1.79x	1.29x
EV / Revenue	3.68x	1.92x	1.79x	1.32x
EV / EBITDA	11.8x	8.02x	10.1x	7x
EV / EBIT	17.6x	13.6x	20.6x	12x
EV / FCF	-	-	-	-
FCF Yield	-	-	-	-
Dividend per Share ²	-	0.06	-	-
Rate of return	-	4.58%	-	-
EPS ²	0.0796	0.0686	0.0411	0.0865
Distribution rate	-	87.4%	-	-
Net sales ¹	4.719	5.932	6.032	9.732
EBITDA ¹	1.474	1.423	1.065	1.832
EBIT ¹	0.987	0.8367	0.5239	1.066
Net income ¹	0.7161	0.5903	0.3528	0.737
Net Debt ¹	-0.8895	-0.3784	0.005767	0.2954
Reference price ²	2.030	1.310	1.265	1.470
Nbr of stocks (in thousands)	9,000	9,000	8,537	8,524
Announcement Date	12/4/23	8/5/24	14/4/25	12/4/26

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
LABORATORIO FARMACEUTICO ERFO S.P.A.	-	-	-	-	10.7M
ELI LILLY AND COMPANY	33.97x	12.34x	25.42x	0.59%	1,035B
JOHNSON & JOHNSON	25.47x	5.87x	15.96x	2.24%	574B
ABBVIE INC.	27.52x	6.71x	13.7x	3.05%	397B
ROCHE HOLDING AG	17.45x	4.31x	10.59x	3.08%	324B
ASTRAZENECA PLC	22.84x	4.75x	13.5x	1.84%	281B
NOVARTIS AG	21.11x	5.44x	13.22x	2.98%	278B
NOVO NORDISK A/S	12.49x	4.69x	9.58x	4.02%	193B
AMGEN INC.	23.02x	6.15x	10.74x	2.85%	191B
GILEAD SCIENCES, INC.	-45.04x	5.44x	30.73x	2.58%	156B
Average	15.43x	6.19x	15.94x	2.58%	342.99B
Weighted average by Cap.	22.87x	7.58x	17.64x	2.09%